Development of BioVie’s NE3107 Asset Featured by the American Diabetes Association
29. Juni 2021 08:00 ET
|
BioVie Inc.
SANTA MONICA, Calif., June 29, 2021 (GLOBE NEWSWIRE) -- BioVie Inc., a clinical-stage company developing innovative drug therapies for the treatment of liver disease and neurological and...
BioVie Added to Russell Microcap® Index
28. Juni 2021 08:00 ET
|
BioVie Inc.
SANTA MONICA, Calif., June 28, 2021 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) ("BioVie" or "Company"), a clinical-stage company developing innovative drug therapies for the treatment of liver...
BioVie Interview to Air on Bloomberg Television U.S. on the RedChip Money Report®
25. Juni 2021 08:00 ET
|
BioVie Inc.
SANTA MONICA, Calif., June 25, 2021 (GLOBE NEWSWIRE) -- BioVie Inc., a clinical-stage company developing innovative drug therapies for the treatment of liver disease and neurological and...
BioVie Announces First Patient Enrolled in BIV201 Phase 2b Clinical Trial for Ascites
24. Juni 2021 08:00 ET
|
BioVie Inc.
SANTA MONICA, Calif., June 24, 2021 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) ("BioVie" or "Company"), a clinical-stage company developing innovative drug therapies for the treatment of liver...
BioVie Receives FDA Guidance for Phase 3 Clinical Trial of BIV201 in HRS-AKI
23. Juni 2021 08:00 ET
|
BioVie Inc.
SANTA MONICA, Calif., June 23, 2021 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) ("BioVie" or "Company"), a clinical-stage company developing innovative drug therapies for the treatment of liver...
BioVie to Present at 31st Annual Oppenheimer Healthcare Conference
11. März 2021 07:00 ET
|
BioVie Inc.
SANTA MONICA, Calif., March 11, 2021 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) ("BioVie" or "Company"), a clinical-stage company developing innovative drug therapies for liver disease, today...
BioVie Commences Patient Screening in Phase 2 Clinical Trial
09. März 2021 07:00 ET
|
BioVie Inc.
SANTA MONICA, Calif., March 09, 2021 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) ("BioVie" or "Company"), a clinical-stage company developing innovative drug therapies for liver disease, today...
BioVie Interview to Air on Bloomberg TV in the US on the RedChip Money Report®
19. Februar 2021 07:00 ET
|
BioVie Inc.
SANTA MONICA, Calif., Feb. 19, 2021 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) ("BioVie" or "Company"), a clinical-stage company developing innovative drug therapies for liver disease, today...
BioVie Interview to Air on Bloomberg International on the RedChip Money Report
30. Oktober 2020 08:00 ET
|
BioVie Inc.
SANTA MONICA, Calif., Oct. 30, 2020 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) ("BioVie" or "Company"), a clinical-stage company developing innovative drug therapies for liver disease, today...
BioVie to Participate in B. Riley Securities Liver Disease Therapeutics Day on October 29, 2020
29. Oktober 2020 08:00 ET
|
BioVie Inc.
SANTA MONICA, Calif., Oct. 29, 2020 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ:BIVI) ("BioVie" or "Company"), a clinical-stage company developing innovative drug therapies for liver disease, today...